480 related articles for article (PubMed ID: 23122333)
1. Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.
Aghili N; Devaney JM; Alderman LO; Zukowska Z; Epstein SE; Burnett MS
Neuropeptides; 2012 Dec; 46(6):367-71. PubMed ID: 23122333
[TBL] [Abstract][Full Text] [Related]
2. An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.
Ashokkumar M; Anbarasan C; Saibabu R; Kuram S; Raman SC; Cherian KM
Thromb Res; 2011 Oct; 128(4):e49-53. PubMed ID: 21762961
[TBL] [Abstract][Full Text] [Related]
3. A myocardial infarction genetic risk score is associated with markers of carotid atherosclerosis.
Hamrefors V; Hedblad B; Engström G; Almgren P; Sjögren M; Melander O
J Intern Med; 2012 Mar; 271(3):271-81. PubMed ID: 22017383
[TBL] [Abstract][Full Text] [Related]
4. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
Liu X; Sun L; Li Z; Gao Y; Hui R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
[TBL] [Abstract][Full Text] [Related]
5. The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.
Tragante V; Doevendans PA; Nathoe HM; van der Graaf Y; Spiering W; Algra A; de Borst GJ; de Bakker PI; Asselbergs FW;
Eur Heart J; 2013 Oct; 34(37):2896-904. PubMed ID: 23828831
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in variables associated with dipeptidyl peptidase 4 genetic polymorphisms in coronary artery disease.
Chiang SM; Ueng KC; Yang YS
Adv Clin Exp Med; 2020 Oct; 29(10):1181-1186. PubMed ID: 33030314
[TBL] [Abstract][Full Text] [Related]
7. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C
Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
9. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction.
Seckin D; Ilhan N; Ilhan N; Ozbay Y
Clin Biochem; 2006 Jan; 39(1):50-4. PubMed ID: 16303122
[TBL] [Abstract][Full Text] [Related]
10. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study.
Horne BD; Carlquist JF; Muhlestein JB; Nicholas ZP; Anderson JL;
Am Heart J; 2007 Nov; 154(5):969-75. PubMed ID: 17967605
[TBL] [Abstract][Full Text] [Related]
11. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
[TBL] [Abstract][Full Text] [Related]
12. Common variants in the haemostatic gene pathway contribute to risk of early-onset myocardial infarction in the Italian population.
Guella I; Duga S; Ardissino D; Merlini PA; Peyvandi F; Mannucci PM; Asselta R
Thromb Haemost; 2011 Oct; 106(4):655-64. PubMed ID: 21901231
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease.
Hlatky MA; Quertermous T; Boothroyd DB; Priest JR; Glassford AJ; Myers RM; Fortmann SP; Iribarren C; Tabor HK; Assimes TL; Tibshirani RJ; Go AS
Am Heart J; 2007 Dec; 154(6):1035-42. PubMed ID: 18035072
[TBL] [Abstract][Full Text] [Related]
14. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
[TBL] [Abstract][Full Text] [Related]
15. Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.
Mälarstig A; Silveira A; Wågsäter D; Öhrvik J; Bäcklund A; Samnegård A; Khademi M; Hellenius ML; Leander K; Olsson T; Uhlén M; de Faire U; Eriksson P; Hamsten A
J Intern Med; 2011 Sep; 270(3):229-36. PubMed ID: 21332844
[TBL] [Abstract][Full Text] [Related]
16. ICAM-1 polymorphisms (G241R, K469E), in coronary artery disease and myocardial infarction.
Aminian B; Abdi Ardekani AR; Arandi N
Iran J Immunol; 2007 Dec; 4(4):227-35. PubMed ID: 18057581
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction.
Antonopoulos AS; Tousoulis D; Antoniades C; Miliou A; Hatzis G; Papageorgiou N; Demosthenous M; Tentolouris C; Stefanadis C
Int J Cardiol; 2013 Sep; 168(1):326-30. PubMed ID: 23041095
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors.
Wiedmann S; Neureuther K; Stark K; Reinhard W; Kallmünzer B; Baessler A; Fischer M; Linsel-Nitschke P; Erdmann J; Schunkert H; Hengstenberg C
Obesity (Silver Spring); 2009 Jul; 17(7):1390-5. PubMed ID: 19197259
[TBL] [Abstract][Full Text] [Related]
19. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence.
Winkelmann BR; Hager J
Pharmacogenomics; 2000 Feb; 1(1):73-94. PubMed ID: 11258599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
